Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about sTM: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| endothelial_damage | biomarker_of | process | 0.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| THBD | cleavage_product | gene | 0.00 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| STMN2 Cryptic Exon Inclusion is the Earliest Loss-of-Functio | 0.760 | als | Causal Sequence of TDP-43 Nuclear Cleara |
| STMN2 Restoration as a Prerequisite for Axon Growth After TD | 0.683 | neurodegeneration | What molecular mechanisms enable functio |
| Integrated Blood Panel of sPDGFRβ, sTM, and Circulating micr | 0.625 | - | What blood-brain barrier permeability ch |
| CHIP-mediated K63-linked ubiquitination redirects oligomeric | 0.380 | protein-biochemistry | Do chaperones selectively recognize path |
| CHIP-mediated K63-linked ubiquitination promotes autophagoso | 0.380 | protein-biochemistry | Do chaperones selectively recognize path |
| Astrocytic SQSTM1 Overexpression Therapy | 0.000 | - | How do non-cell autonomous effects of au |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.745
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning sTM in their description or question text